Clinical Trial Update: Prevalence and Level of Thienopyridine Resistance Seen in a Contemporary Percutaneous Coronary Intervention or Coronary Artery Bypass Graft Population

View source ↗

Summary

This clinical trial update reports on the prevalence and level of thienopyridine (antiplatelet) resistance in patients undergoing percutaneous coronary interven…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• PRASUGREL (prasugrel)

Snippet

Sponsor: Medstar Health Research Institute | Conditions: Increased Drug Resistance | Status: UNKNOWN